News
FDA approves Kyowa Kirin's new Parkinson's drug Nourianz
The FDA has approved a new drug for Parkinson’s disease, giving the nod to Kyowa Kirin’s Nourianz (istadefylline) as an add-on to dopamine replacement drugs to reduce “off” episodes when th
